16:08 EDT Crinetics files to sell 8.33M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CRNX:
- Crinetics Pharmaceuticals’ Paltusotine Shows Promising Results
- Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-2 Study in Acromegaly Patients
- Crinetics price target raised to $54 from $48 at Oppenheimer
- Crinetics Pharmaceuticals Advances with Promising Phase 2 Results
- Crinetics reports topline results from paltusotine study